Luo Y - Search Results

1

LncRNA00492 is required for marginal zone B-cell development.

Wang F, Cui D, Zhang Q, Shao Y, Zheng B, Chen L, Luo Y, Yuan L, Wang D. Wang F, et al. Among authors: luo y. Immunology. 2022 Jan;165(1):88-98. doi: 10.1111/imm.13408. Epub 2021 Sep 7. Immunology. 2022. PMID: 34435359 Free article.

2

The LncRNA RP11-279C4.1 Enhances the Malignant Behaviour of Glioma Cells and Glioma Stem-Like Cells by Regulating the miR-1273g-3p/CBX3 Axis.

Wang F, Zhang L, Luo Y, Zhang Q, Zhang Y, Shao Y, Yuan L. Wang F, et al. Among authors: luo y. Mol Neurobiol. 2021 Jul;58(7):3362-3373. doi: 10.1007/s12035-021-02337-6. Epub 2021 Mar 10. Mol Neurobiol. 2021. PMID: 33694060

3

The LncRNA RP11-301G19.1/miR-582-5p/HMGB2 axis modulates the proliferation and apoptosis of multiple myeloma cancer cells via the PI3K/AKT signalling pathway.

Wang F, Luo Y, Zhang L, Younis M, Yuan L. Wang F, et al. Among authors: luo y. Cancer Gene Ther. 2022 Mar;29(3-4):292-303. doi: 10.1038/s41417-021-00309-5. Epub 2021 Mar 11. Cancer Gene Ther. 2022. PMID: 33707625

4

Iguratimod-encapsulating PLGA-NPs induce human multiple myeloma cell death via reactive oxygen species and Caspase-dependent signalling.

Wang F, Younis M, Luo Y, Zhang L, Yuan L. Wang F, et al. Among authors: luo y. Int Immunopharmacol. 2021 Jun;95:107532. doi: 10.1016/j.intimp.2021.107532. Epub 2021 Mar 20. Int Immunopharmacol. 2021. PMID: 33756230

5

Down-regulation of LncRNA 2900052N01Rik inhibits LPS-induced B cell function in vitro.

Wang F, Luo Y, Zhang L, Younis M, Yuan L. Wang F, et al. Among authors: luo y. Cell Immunol. 2021 May;363:104321. doi: 10.1016/j.cellimm.2021.104321. Epub 2021 Mar 6. Cell Immunol. 2021. PMID: 33773377

6

Gene deficiency and pharmacological inhibition of caspase-1 confers resilience to chronic social defeat stress via regulating the stability of surface AMPARs.

Li MX, Zheng HL, Luo Y, He JG, Wang W, Han J, Zhang L, Wang X, Ni L, Zhou HY, Hu ZL, Wu PF, Jin Y, Long LH, Zhang H, Hu G, Chen JG, Wang F. Li MX, et al. Among authors: luo y. Mol Psychiatry. 2018 Mar;23(3):556-568. doi: 10.1038/mp.2017.76. Epub 2017 Apr 18. Mol Psychiatry. 2018. PMID: 28416811 Free PMC article.

7

A feedforward circuit between KLF5 and lncRNA KPRT4 contributes to basal-like breast cancer.

Du G, Sun J, Li Z, Zhang Q, Liu W, Yang C, Zhao P, Wang X, Yin Q, Luo Y, Song J, Wen Y, Wang H, Chen CH, Hu G, Zhou Z, Mao X, Liu W, Liu Z, Jiang D, Chen C. Du G, et al. Among authors: luo y. Cancer Lett. 2022 May 28;534:215618. doi: 10.1016/j.canlet.2022.215618. Epub 2022 Mar 6. Cancer Lett. 2022. PMID: 35259457

8

The roles and regulation of the KLF5 transcription factor in cancers.

Luo Y, Chen C. Luo Y, et al. Cancer Sci. 2021 Jun;112(6):2097-2117. doi: 10.1111/cas.14910. Epub 2021 May 3. Cancer Sci. 2021. PMID: 33811715 Free PMC article. Review.

9

DNA damage-inducible transcript 3 restrains osteoclast differentiation and function.

Yang B, Sun H, Jia M, He Y, Luo Y, Wang T, Wu Y, Wang J. Yang B, et al. Among authors: luo y. Bone. 2021 Dec;153:116162. doi: 10.1016/j.bone.2021.116162. Epub 2021 Aug 27. Bone. 2021. PMID: 34455116

10

KLF5 inhibition potentiates anti-PD1 efficacy by enhancing CD8⁺ T-cell-dependent antitumor immunity.

Wu Q, Liu Z, Gao Z, Luo Y, Li F, Yang C, Wang T, Meng X, Chen H, Li J, Kong Y, Dong C, Sun S, Chen C. Wu Q, et al. Among authors: luo y. Theranostics. 2023 Feb 21;13(4):1381-1400. doi: 10.7150/thno.82182. eCollection 2023. Theranostics. 2023. PMID: 36923542 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29,309 results

Search Page

Filters